Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes

Journal of Medical Microbiology

Volumn 58, Issue 7, 2009, Pages 845-854

  Zhang, Weidong ^a,b   Li, Wanyi ^a   Li, Yan ^c   Li, Hong ^a   Wang, Baoning ^a   Wang, Fengping ^a   Zhu, Yuanjun ^a   Jiang, Zhonghua ^a   Zhong, Li ^a   Li, Mingyuan ^a,c  

^a SICHUAN UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEMAGGLUTININ; SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EUKARYOTIC CELL; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNIZATION; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSFECTION; VACCINES, DNA;

EID: 67650165364     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.006825-0     Document Type: Article

References (41)

1. Alheim, M., Lazdina, U., Milich, D. R. & Sallberg, M. (2001). Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant. J Immunol Methods 258, 157-167. (Pubitemid 33016536)
2. Alymova, I. V., Taylor, G. & Portner, A. (2005). Neuraminidase inhibitors as antiviral agents. Curr Drug Targets Infect Disord 5, 401-409.
3. Aymard-Henry, M., Coleman, M. T., Dowdle, W. R., Laver, W. G., Schild, G. C. & Webster, R. G. (1973). Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ 48, 199-202.
4. Bona, C., Radu, D. & Kodera, T. (2004). Molecular studies on the diversification of haemagglutinin-specific human neonatal repertoire subsequent to immunization with naked DNA. Vaccine 22, 1624-1630. (Pubitemid 38447209)
5. Bot, A., Antohi, S., Bot, S., Garcia-Sastre, A. & Bona, C. (1997). Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int Immunol 9, 1641-1650. (Pubitemid 27494127)
6. Carter, L. L. & Dutton, R. W. (1996). Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 8, 336-342. (Pubitemid 26229654)
7. Chen, J., Lee, K. H., Steinhauer, D. A., Stevens, D. J., Skehel, J. J. & Wiley, D. C. (1998). Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95, 409-417. (Pubitemid 28507328)
8. Chen, J., Fang, F., Li, X., Chang, H. & Chen, Z. (2005). Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23, 4322-4328. (Pubitemid 40991237)
9. De Mare, A., Bungener, L. B., Regts, J., de Vries-Idema, J., Van der Zee, A. G., Wilschut, J. & Daemen, T. (2008). The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity. Vaccine 26, 2314-2321.
10. Donnelly, J. J., Ulmer, J. B., Shiver, J. W. & Liu, M. A. (1997). DNA vaccine. Annu Rev Immunol 15, 617-648.
11. Feltquate, D. M., Heaney, S., Webster, R. G. & Robinson, H. L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158, 2278-2284. (Pubitemid 127470012)
12. Fiers, W., Neirynck, S., Deroo, T., Saelens, X. & Jou, W. M. (2001). Soluble recombinant influenza vaccines. Philos Trans R Soc Lond B Biol Sci 356, 1961-1963.
13. Gruber, W. C. (2002). The role of live influenza vaccines in children. Vaccine 20, S66-S73. (Pubitemid 34756350)
14. He, X. S., Mahmood, K., Maecker, H. T., Holmes, T. H., Kemble, G. W., Arvin, A. M. & Greenberg, H. B. (2003). Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis 187, 1075-1084. (Pubitemid 36399350)
15. He, X. S., Holmes, T. H., Zhang, C., Mahmood, K., Kemble, G. W., Lewis, D. B., Dekker, C. L., Greenberg, H. B. & Arvin, A. M. (2006). Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80, 11756-11766. (Pubitemid 44788888)
16. Johansson, B. E., Grajower, B. & Kilbourne, E. D. (1993). Infectionpermissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 11, 1037-1039. (Pubitemid 23304001)
17. Johnson, P. A., Conway, M. A., Daly, J., Nicolson, C., Robertson, J. & Mills, K. H. (2000). Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol 81, 1737-1745. (Pubitemid 30427079)
18. Lambkin, R., Novelli, P., Oxford, J. & Gelder, C. (2004). Human genetics and responses to influenza vaccination: clinical implication. Am J Pharmacogenomics 4, 293-298. (Pubitemid 39452416)
19. Larregina, A. T. & Falo, L. D., Jr (2000). Generating and regulating immune responses through cutaneous gene delivery. Hum Gene Ther 11, 2301-2305. (Pubitemid 30826407)
20. Li, X., Fang, F., Song, Y., Yan, H., Chang, H., Sun, S. & Chen, Z. (2006). Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection. DNA Cell Biol 25, 197-205. (Pubitemid 43668281)
21. Licht, T. & Peschel, C. (2002). Restoration of transgene expression in hematopoietic cells with drug-selectable marker genes. Curr Gene Ther 2, 227-234.
22. McDonald, N. J., Smith, C. B. & Cox, N. J. (2007). Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J Gen Virol 88, 3209-3213. (Pubitemid 350201829)
23. Oran, A. E. & Robinson, H. L. (2003). DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-c and IL-4-producing CD4+ and CD8+ T cells. J Immunol 171, 1999-2005. (Pubitemid 36974544)
24. Palese, P., Tobita, K., Ueda, M. & Compans, R. W. (1974). Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397-410.
25. Pertmer, T. M., Roberts, T. R. & Haynes, J. R. (1996). Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70, 6119-6125. (Pubitemid 26266828)
26. Plotkin, J. B., Dushoff, J. & Levin, S. A. (2002). Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A 99, 6263-6268. (Pubitemid 34493300)
27. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
28. Robinson, H. L., Hunt, L. A. & Webster, R. G. (1992). Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957-960.
29. Sad, S., Marcotte, R. & Mosmann, T. R. (1995). Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2, 271-279.
30. Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., Kemble, G. W., Arvin, A. M. & Greenberg, H. B. (2007). Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81, 215-228. (Pubitemid 44975162)
31. Shen, Y., Muramatsu, S. I., Ikeguchi, K., Fujimoto, K. I., Fan, D. S., Ogawa, M., Mizukami, H., Urabe, M., Kume, A. & other authors (2000). Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. Hum Gene Ther 11, 1509-1519. (Pubitemid 30670603)
32. Snapper, C. M. & Paul, W. E. (1987). Interferon-c and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947. (Pubitemid 17107942)
33. Tamura, S., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. & Kurata, T. (1992a). Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149, 981-988.
34. Tamura, S. I., Asanuma, H., Ito, Y., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C., Kurata, T. & Oya, A. (1992b). Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 22, 477-481.
35. Tighe, H., Corr, M., Roman, M. & Raz, E. (1998). Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19, 89-97. (Pubitemid 28097655)
36. Ulmer, J. B. (2002). Influenza DNA vaccines. Vaccine 20, S74-S76.
37. Ulmer, J. B., Donnelly, J. J., Paker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M. & other authors (1993). Heterologous protection against influenza by infection of DNA encoding a viral protein. Science 259, 1745-1749.
38. Wilson, J. C. & Itzstein, M. (2003). Recent strategies in the search for new anti-influenza therapies. Curr Drug Targets 4, 389-408. (Pubitemid 36758318)
39. Wilson, I. A., Skehel, J. J. & Wiley, D. C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A ° resolution. Nature 289, 366-373.
40. Zhang, F., Chen, J., Fang, F., Zhou, Y., Wu, J., Chang, H., Zhang, R., Wang, F., Li, X. & other authors (2005). Maternal immunization with both hemagglutinin and neuraminidase expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 24, 758-765. (Pubitemid 41735010)
41. Zhang, W., Li, M., Cao, K., Yang, J., Shi, Q., Wang, B., Jiang, Z. & Li, H. (2006). Construction of eukaryotic expressing plasmids encoding HA and HA1 of influenza A virus and their transient expression in HEK293 cells. J Huazhong Univ Sci Technolog Med Sci 26, 225-230.